Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akebia Therapeutics, Inc. - Common Stock (NQ:AKBA)

2.040 -0.090 (-4.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Akebia Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Recap: Akebia Therapeutics Q4 Earnings
Via Benzinga
Earnings Scheduled For March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
Earnings Preview For Akebia Therapeutics
Via Benzinga
Earnings Outlook For Akebia Therapeutics
Via Benzinga
Analyst Highly Confident In Akebia Therapeutics' Kidney Disease-Associated Anemia Drug, Stock Soars
HC Wainwright has upgraded Akebia Therapeutics Inc (NASDAQ: AKBA) from Neutral to Buy rat 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
Via Benzinga
Earnings Outlook For Akebia Therapeutics
Via Benzinga
Where Akebia Therapeutics Stands With Analysts
Via Benzinga
Analyst Ratings for Akebia Therapeutics
Via Benzinga
The Latest Analyst Ratings for Akebia Therapeutics
Via Benzinga
Earnings Scheduled For August 25, 2023
Companies Reporting Before The Bell • Hibbett (NASDAQ:HIBB) is likely to report quarterly earnings at $0.73 per share on revenue of $376.11 million. 
Via Benzinga
Intuit, Hibbett And 3 Stocks To Watch Heading Into Friday
With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Fear & Greed Index Moves To 'Fear' Zone Ahead Of Powell's Speech
The CNN Money Fear and Greed index moved to the "Fear" zone on Thursday. U.S. stocks closed sharply lower on Thursday ahead of a key speech from Federal Reserve chair Jerome Powell at the Jackson Hole... 
Via Benzinga
Topics Economy
Exposures Interest Rates
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Akebia Therapeutics's Return On Capital Employed Overview
Via Benzinga
Earnings Preview: Akebia Therapeutics
Via Benzinga
4 Analysts Have This to Say About Akebia Therapeutics
Via Benzinga
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Pocket Change, Big Gains: 3 Penny Stocks Ready to Boom
Are you looking for High Return Penny Stocks for high growth? Here are three penny stocks with rapid development and great market potential. 
Via InvestorPlace
Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2
Various names in the biotech sector are seeing a substantial increase in search activity today. Such names include the likes of Akebia Therapeautics, Corvus Pharmaceuticals, and Mirati Therapeutics. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Shares of Akebia Therapeutics Were Up Tuesday
An approval in the U.K. for Akebia's symptomatic anemia therapy boosted the stock. 
Via The Motley Fool
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with the biggest pre-market stock movers traders will want to keep in mind while trading on Tuesday! 
Via InvestorPlace
Akebia Says Vadadustat Non Inferior To Standard Care In Alternative Dosing Study In Anemia Patients On Dialysis
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.